Syschem (India) — 360° view

Syschem (India), a company in the Pharmaceuticals industry, reported revenue of ₹113 crore and net profit of ₹1.91 crore for the September 2026 quarter.

Syschem (India) (BSE: SYSCHEM) closed at ₹30.68 on 20 Nov 2026, down 46.0% over the past year. Its market capitalisation is ₹164 crore and it trades at 26.7 times earnings.

Share price
₹30.68 (20 Nov 2026)
Market cap
₹164 Cr (20 Nov 2026)
P/E
26.74 (20 Nov 2026)
Revenue
₹113 Cr (September 2026 quarter)
Net profit
₹2 Cr (September 2026 quarter)
ROCE
15.9% (FY26)
ROE
10.2% (FY26)
Book value
₹26.0 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹57.80 / ₹28.81 (20 Nov 2026)
1-year return
-46.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: SYSCHEM

Incorporated in 1993, Syschem (India) Limited manufactures Active Pharmaceuticals Ingredients (APIs) and bulk drugs.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.